Atlas Trials

Pharmacokinetic Study of SPARC1613 and reference1613 in Subjects With Locally Recurrent or Metastatic Breast Cancer

Clinical trial NCT03109249 · COMPLETED

Trial details

NCT number
NCT03109249
Sponsor
Sun Pharma Advanced Research Company Limited
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Recurrent or Metastatic Breast Cancer
Start date
2017-01-14
Primary completion
2018-10-04
Enrollment
142

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.